泸州医学院学报
瀘州醫學院學報
로주의학원학보
JOURNAL OF LUZHOU MEDICAL COLLEGE
2014年
1期
114-116
,共3页
冠心宁注射液%脑出血%脑心综合征%心电图%心肌酶
冠心寧註射液%腦齣血%腦心綜閤徵%心電圖%心肌酶
관심저주사액%뇌출혈%뇌심종합정%심전도%심기매
Guanxinning injections%Cerebral hemorrhage%Cerebrocardiac syndrome%ECG%Myocardial enzyme
目的：观察冠心宁注射液治疗脑出血后脑心综合征患者的有效性。方法：将62例脑出血后脑心综合征患者按是否使用冠心宁注射液而分为治疗组和对照组，治疗组（32例）采用常规治疗基础上加用冠心宁注射液治疗，对照组（30例）给予常规治疗，分析2组患者临床症状、心电图、血清心肌酶谱水平的变化及不良反应。结果：治疗组总有效率（84.38%）明显高于对照组（53.33%）（P＜0.01）；治疗组治疗后血清 AST、LDH、CK、MB 含量分别为（65.59±13.71）、（100.22±17.69）、（40.18±9.46）、（280.82±20.84）IU/L，对照组治疗后血清AST、LDH、CK、MB含量分别为（132.22±16.78）、（219.97±29.54）、（84.13±11.62）、（422.51±33.76）IU/L，治疗组治疗后血清心肌酶谱水平皆明显低于对照组（P＜0.001）；两组皆无明显负反应。结论：冠心宁注射液能改善脑出血后脑心综合征患者的临床症状，纠正其心电异常，下调其心肌酶谱水平。
目的：觀察冠心寧註射液治療腦齣血後腦心綜閤徵患者的有效性。方法：將62例腦齣血後腦心綜閤徵患者按是否使用冠心寧註射液而分為治療組和對照組，治療組（32例）採用常規治療基礎上加用冠心寧註射液治療，對照組（30例）給予常規治療，分析2組患者臨床癥狀、心電圖、血清心肌酶譜水平的變化及不良反應。結果：治療組總有效率（84.38%）明顯高于對照組（53.33%）（P＜0.01）；治療組治療後血清 AST、LDH、CK、MB 含量分彆為（65.59±13.71）、（100.22±17.69）、（40.18±9.46）、（280.82±20.84）IU/L，對照組治療後血清AST、LDH、CK、MB含量分彆為（132.22±16.78）、（219.97±29.54）、（84.13±11.62）、（422.51±33.76）IU/L，治療組治療後血清心肌酶譜水平皆明顯低于對照組（P＜0.001）；兩組皆無明顯負反應。結論：冠心寧註射液能改善腦齣血後腦心綜閤徵患者的臨床癥狀，糾正其心電異常，下調其心肌酶譜水平。
목적：관찰관심저주사액치료뇌출혈후뇌심종합정환자적유효성。방법：장62례뇌출혈후뇌심종합정환자안시부사용관심저주사액이분위치료조화대조조，치료조（32례）채용상규치료기출상가용관심저주사액치료，대조조（30례）급여상규치료，분석2조환자림상증상、심전도、혈청심기매보수평적변화급불량반응。결과：치료조총유효솔（84.38%）명현고우대조조（53.33%）（P＜0.01）；치료조치료후혈청 AST、LDH、CK、MB 함량분별위（65.59±13.71）、（100.22±17.69）、（40.18±9.46）、（280.82±20.84）IU/L，대조조치료후혈청AST、LDH、CK、MB함량분별위（132.22±16.78）、（219.97±29.54）、（84.13±11.62）、（422.51±33.76）IU/L，치료조치료후혈청심기매보수평개명현저우대조조（P＜0.001）；량조개무명현부반응。결론：관심저주사액능개선뇌출혈후뇌심종합정환자적림상증상，규정기심전이상，하조기심기매보수평。
Objective:To observe the effectiveness of Guanxinning injection on cerebrocardiac syndrome (CCS) induced by cerebral hemorrhage. Methods: 62 cases of CCS induced by cerebral hemorrhage were divided into treatment group(32 cases) and control group(30 cases). The control group was given conventional treatment,while the treatment group given conventional treatment combined with Guanxinning injections. The clinical efficacy,ECG,serum myocardial enzyme and adverse reactions were analysed. Results: The total effective rate of the treatment group (84.38%)was was significantly higher than that of the control group (53.33%)(P<0.01).The serum AST, LDH,CK, and MB content were (65.59 ± 13.71)、(100.22 ± 17.69)、(40.18 ± 9.46)、(280.82 ± 20.84 )IU/L respectively in treatment group,and (132.22 ± 16.78)、(219.97 ± 29.54)、(84.13 ± 11.62)、(422.51 ± 33.76)IU/L respectively in control group;the treatment group was significantly lower (P<0.001).The two groups had no significant adverse reaction. Conclusion: Guanxinning Injections can improve the clinical symptoms,correct the cardiac electrical abnormalities, and reduce the myocardial enzyme level of CCS induced by cerebral hemorrhage.
